Massachusetts Governor Charlie Baker signed into law a compromise healthcare bill that calls for reimbursing cancer patients for the out-of-pocket expenses associated with clinical trial participation and creating across the board reimbursement programs in the state.
Stephanie Halene was named chief of hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.
David Haggstrom was named director of Regenstrief Institute's William M. Tierney Center for Health Services Research.
Sue S. Yom was named editor-in-chief of the International Journal of Radiation Oncology, Biology, Physics (Red Journal), the flagship scientific journal of the American Society for Radiation Oncology.
Dana-Farber Cancer Institute has received a $50 million donation from the Pan-Mass Challenge.
Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center received a one-year, $135,000 grant from the Connecticut Lions Eye Research Foundation to fund uveal melanoma research.
Friends of Cancer Research has launched a collaboration that aims to address concerns about the lack of consistency in determining homologous recombination deficiency—HRD—status, its prognostic value, and its use as a predictive biomarker.
Jack. T. Evjy, Chang Oh Turkmani and Elizabeth M. Fago were appointed to the National Cancer Advisory Board Dec. 8.
GRAIL and United Kingdom's National Health Service are collaborating to make GRAIL's multi-cancer early detection blood test, Galleri, available to UK patients starting in 2021.
Raymond Bergan was named deputy director of the Fred & Pamela Buffett Cancer Center at University of Nebraska Medical Center.
